MGLL Antilichaam - N-terminalgebied: FITC (ARP52321 P050-FITC)

Monoglyceride lipase

MGL, HUK5, MAGL, HU-K5

11343

Q6IBG9

NP_009214

Human, Mouse, Rat, Dog, Pig, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human MGLL

Monoglyceride lipase (MGLL; EC 3.1.1.23) functions together with hormone-sensitive lipase (LIPE; MIM 151750) to hydrolyze intracellular triglyceride stores in adipocytes and other cells to fatty acids and glycerol. MGLL may also complement lipoprotein lipase (LPL; MIM 238600) in completing hydrolysis of monoglycerides resulting from degradation of lipoprotein triglycerides (Karlsson et al., 2001 [PubMed 11470505]) .

CHGB

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

MGLL is supported by BioGPS gene expression data to be expressed in ACHN

0.5 mg/ml

Dog: 93%; Human: 100%; Mouse: 79%; Pig: 86%; Rabbit: 93%; Rat: 79%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

34kDa

Wet Ice

313

MGLL

MGLL

Rabbit

Monoglyceride lipase

NM_007283

METGPEDPSSMPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGT